deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03846570

Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial (FORZA)

Sponsor: Chiesi Farmaceutici S.p.A.

Conditions Bronchiectasis
Interventions Formoterol-beclomethasone Placebo
Updated 8 times since 2019 Last updated: Feb 28, 2023 Started: Jan 29, 2019 Primary completion: Jul 5, 2022 Completion: Jul 5, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient inclusion rate (due to COVID-19 pandemic)

Other terminated trials from Chiesi Farmaceutici S.p.A.

More terminations from Chiesi Farmaceutici S.p.A.

Other Bronchiectasis trials with similar outcome

Browse all Bronchiectasis trials

This PHASE3 trial investigates Bronchiectasis and is currently terminated or withdrawn. Chiesi Farmaceutici S.p.A. leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Apr 2022 · 6 months · monthly snapshotUnknown Status~Apr 2022 – ~Apr 2023 · 12 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Apr 2023 — Jul 2024 [monthly]

    Terminated PHASE3

    Status: Recruiting → Terminated

  5. Apr 2022 — Apr 2023 [monthly]

    Recruiting PHASE3

    Status: Unknown Status → Recruiting

▶ Show 3 earlier versions

  1. Oct 2021 — Apr 2022 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  2. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  3. Mar 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chiesi Farmaceutici S.p.A.
  • Erasmus Medical Center
Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations